ABSTRACT
Introduction
The menopause is the permanent discontinuance of menstruation due to the loss of ovarian follicular activity. Clinically, menopause is diagnosed after twelve months of amenorrhea, so the time of the final menses is determined retrospectively 1 . Loss of ovarian follicular . The incidence of cardiovascular events gradually increases in postmenopausal women, which may be due to increases in risk factors and diminished levels of estrogen 3, 4 . Atherosclerotic cardiovascular disease is responsible for approximately one-third of deaths worldwide 5 . Atherosclerosis is a particular form of the systemic chronic low-grade inflammatory process resulting from interactions between humoral, cellular mediators and multiple risk factors 6 . The important role of neutrophils, lymphocytes, monocytes in atherosclerosis has been well established [7] [8] [9] [10] [11] . The NLR is used as indicators of systemic inflammation in various conditions. Also, it was suggested that NLR has prognostic value in some atherosclerotic diseases 12, 13 .
It is well-known that menopause has unfavorable effects on lipid profile, but its impact on neutrophil, lymphocyte count, and NLR is unknown 2, 4, 14 . The goal of this study was to determine if there were differences in inflammatory parameters of complete blood count (CBC) regarding the neutrophil, lymphocyte count, and NLR between premenopausal and postmenopausal women and to evaluate whether the NLR could be a predictor of chronic inflammation.
Methods
This retrospective study included 448 healthy women (n=448) who were admitted to our cardiology clinic between March 2013 and May 2014. These 448 women were divided into two groups, a premenopausal group (n=295) and the postmenopausal group (n=153). All patients were provided informed consent, and the study was approved by the local ethic committee.
Exclusion criteria included the presence of the irregular menstrual cycles, history of hormone replacement therapy (HRT), infection in the last one month, high body temperature (>38 o C), and the history of an inflammatory disease. The patients with a known coronary artery disease, valvular heart disease, history of rhythm disturbances, abnormal electrocardiography (ECG), left ventricular systolic dysfunction, cerebral or peripheral vascular disease, hematological disorders, renal or liver insufficiency, and thyroid dysfunction have also excluded the study.
All subjects were evaluated with physical examination, CBC, routine biochemical examination, ECG and echocardiography (ECHO). Venous blood samples were taken from patients after a 12-hour fasting and analyzed for CBC parameters. The CBC parameters including the white blood count (WBC), hemoglobin (Hb), platelet, mean platelet volume (MPV), neutrophil, and lymphocyte were tested. Also, the biochemical parameters including the total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), lowdensity lipoprotein cholesterol (LDL-C), triglyceride (TG), and glucose levels were tested. NLR was calculated as the ratio of neutrophil cell count to lymphocyte cell count using COBAS c311 analyzer system (Roche Diagnostics, Germany).
Statistical Analysis
The Statistical Package for the Social Sciences software (SPSS 20.0 for Windows, Inc., Chicago, IL, USA) was used for all statistical calculations. The KolmogorovSmirnov test was used to determine the distribution of data from continuous variables. Normally distributed data were given as mean±standard deviation (SD), data with non-normal distributions were expressed as median, and the interquartil ratio (IQR), and dichotomous data were given as a percent. A significance level of the difference between the premenopausal and postmenopausal group was analyzed using Student-t test for parametric value and MannWhitney U test for not normal distributing variables. Differences between dichotomous variables were evaluated using the χ 2 test. Correlations between NLR and various parameters were assessed using Spearman correlation test. Statistical significance was defined as p<0.05.
Results
The median age of the all study population was 42 years (IQR: 35.25-53 years ) women were recorded respectively. Compared with premenopausal women, weight, BMI, Hb, Hct and fasting blood glucose levels were significantly higher in postmenopausal women, whereas mean height and smoking ratio were comparable between two groups. There were no significant differences between two groups with respect to MCV and RDW values. Postmenopausal women showed statistically significant increase in serum TC, TG, LDL-C levels. TC/HDL-C, LDL-C/HDL-C, and TG/HDL-C ratio were significantly increased in postmenopausal women as compared to that in premenopausal women. In contrast, HDL-C levels did not show a statistically significant difference between two groups. Clinical and laboratory features of two groups are given in Table 1 .
Our study has primarily focused on the effects of menopause on neutrophil, lymphocyte count and NLR in healthy women who do not receive an HRT. Table 2 .
There were negative correlations between NLR and FBG, Hb, MCHC, RDW, TC, LDL-C, TG, LDL-C/ HDL-C and TC/HDL-C levels. Parameters correlated with NLR are given in Table 3 .
Discussion
Menopause is defined as the permanent discontinuation of menstruation resulting from loss of ovarian follicular activity and l2 months of amenorrhea from the last menstrual period. The final menstrual period (FMP) usually occurs between the ages of 40 and 58. The average age of menopause is 51 years 15, 16 . World Health Organization (WHO) has recommended the use of the following definitions for menopause status categories. Premenopausal period is defined as the entire reproductive period before FMP and the postmenopausal period is defined as dating from the FMP hormonal changes (decreased level of estrogen, especially E2) are associated with the development of the atherosclerotic cardiovascular disease. Changes in estrogen level may influence inflammatory processes during the menopausal period. It has been shown that menopause causes low grade of systemic inflammation 19 . Several studies demonstrated that chronic low grade inflammation increases the risk of cardiovascular disease 20 Besides, HRT has been shown to reduce serum markes of inflammation and the incidence of cardiovascular disease in postmenopausal women [21] [22] [23] . WBC count refers to the total number of white blood cells in the peripheral blood produced by the bone marrow. It has been related to different cardiovascular risk factors, such as smoking, obesity, and hypertension 10, 24, 25 . WBC and its fractions including neutrophils and lymphocytes provide an indirect estimate of inflammatory status 10, 13, 26 . NLR, the simple ratio obtained from a differential blood cell count, was introduced as a marker to determine inflammation in various disorders such as cardiovascular diseases, malignancies, and diabetes mellitus. It is used as a predictor of adverse cardiovascular outcomes in atherosclerotic heart disease. It was demonstrated that it has an association with the coronary artery disease, pulmonary arterial hypertension, coronary ectasia, arrhythmias, atherosclerotic coronary artery disease, as well as the severity of acute coronary syndromes and the survival after coronary artery disease 13, [26] [27] [28] [29] [30] .
Several studies have demonstrated that the parameters of blood samples including TC, LDL, and TG levels are increased after menopause 4, 31 . However, the effect of menopause on neutrophil, lymphocyte count, and stages centered on the FMP (Stage 0). The reproductive phase was divided into Stages -5, -4, and -3 corresponding to early, peak, and late, respectively. The menopausal transition phase consisted of Stage -2 (early) and Stage -1 (late), and the postmenopausal phase contained Stages +1 (early) and +2 (late) 6 . The oocytes in the ovaries undergo atresia throughout a women's life cycle, and both the quantity and quality of follicles fall into a sharp decline. Estradiol (E2), the most potent form of the hormone, is predominant before menopause while estrone (E1) is the primary form of menopause. Also, levels of both hormones are considerably lower in postmenopausal period than the premenopausal period 17, 18 .
Studies have shown that after menopause, women demonstrate an increased risk of atherosclerotic heart disease 17, 18 . It is assumed that menopause-related This research is the first, regarding the investigation of neutrophil, lymphocyte count and NLR in premenopausal and postmenopausal healthy women. Our study has primarily focused on the effects of menopause on neutrophil, lymphocyte count and NLR in healthy women who do not receive an HRT. To the best of our knowledge, no study has investigated the NLR in healty postmenopausal women, for this reason we were unable to compare our results with other studies. Angeli et al. 32 examined 298 hypertensive postmenopausal women and showed that, in addition to traditional risk factors, neutrophil count identifies hypertensive postmenopausal women at increased risk of cardiovascular disease. In that study, total WBC count did not show any association with cardiovascular events. Another study found that NLR was significantly increased in postmenopausal osteopenic women, which may be used as the indicator of bone loss 33 .
TC, LDL-C and TG levels progressively increase during menopausal period 31 . However, studies examining the influence of menopause on HDL-C have yielded conflicting results. Some concluded that the menopause is not associated with change in HDL-C, while others concluded that menopause is associated with a decline in HDL-C 34 . In our study TC, LDL-C and TG levels were significantly higher in postmenopausal women compared to that of premenopausal women. In contrast, HDL-C levels did not show a statistically significant difference between two groups.
In conclusion, NLR which is an emerging marker of inflammation, is used as a predictor of adverse outcomes in atherosclerotic heart disease. Our results suggest that menopause does not alter NLR in healthy women. For this purpose, the large-scale controlled prospective studies are needed to assess the effect of menopause on humoral and cellular inflammatory markers.
Limitation of the Study
The main limitations of this study include: single centered/relatively small number of subjects and retrospective design; did not asses the hormone levels; invasive study was not performed to exclude coronary artery disease; and humoral and cellular inflammatory markers were missing from the study data.
